# Hyoscin-Butylbromide

## Escopan inj 20mg/1mL

| TAH Drug Code      | [IESC](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IESC)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Gastrointestinal spasms and hypermotility, biliary tract spasms and motility disorders, urinary tract spasms, and spasmodic conditions of the female reproductive system.                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Dosing             | Adult 20 mg 1-5 times daily IM/IV/SC.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Contraindications  | Patients with a history of allergic reactions to Hyoscine-N-butylbromide or any component of the product. Untreated narrow-angle glaucoma. Prostatic hypertrophy with urinary retention. Mechanical gastrointestinal obstruction. Paralytic or obstructive ileus. Megacolon. Tachycardia. Myasthenia gravis. Hyoscine-N-butylbromide injection is contraindicated for intramuscular administration. For patients receiving anticoagulant therapy, intramuscular administration is not recommended due to the risk of intramuscular hematoma. Subcutaneous or intravenous administration should be used instead. |
| Adverse Effects    | Common: Xerostomia (29-approximately 66%), Dizziness (12-<16.7%), Somnolence (8%), Blurred vision (<16.7%), Mydriasis (4-<16.7%). Serious: Glaucoma, Psychotic disorder, Eclamptic seizure.                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Pregnancy          | No Data                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| More Info          | [UpToDate](https://www.uptodate.com/contents/hyoscin-butylbromide-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

